(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 26.36%14.44B | 11.95%12.82B | 29.54%13.43B | 8.16%12.05B | 4.80%11.43B | 6.11%11.45B | 12.44%10.37B | -12.39%11.14B | 1.26%10.9B | -5.02%10.79B |
Transactional financial assets | 417.50%1.07M | -71.76%31.09M | -99.98%116.99K | -99.51%3.09M | -99.96%206.37K | -82.26%110.12M | 158.90%623.02M | 95.39%636.27M | 309.01%510.11M | -84.41%620.84M |
Notes receivable and accounts receivable | 49.63%373.35M | 13.08%295.42M | 12.96%242.53M | -28.90%205.65M | -7.88%249.51M | -16.77%261.26M | 7.23%214.71M | 14.61%289.24M | 19.25%270.86M | -21.33%313.91M |
-Notes receivable | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Accounts receivable | 49.63%373.35M | 13.08%295.42M | 12.96%242.53M | -28.90%205.65M | -7.88%249.51M | -16.77%261.26M | 7.23%214.71M | 14.61%289.24M | 19.25%270.86M | -21.33%313.91M |
Other receivables (including interest and dividends) | -22.51%1.69B | -41.60%1.68B | -45.51%1.72B | -55.97%2.09B | -46.68%2.18B | -48.35%2.88B | -62.00%3.15B | -40.59%4.75B | -53.78%4.09B | -38.64%5.58B |
-Dividend receivable | 0.00%30M | 0.00%30M | --30M | 33.79%456.14M | --30M | --30M | ---- | 18.05%340.94M | ---- | ---- |
-Accrued interest receivable | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other receivable | ---- | -42.03%1.65B | ---- | -62.90%1.64B | ---- | -48.89%2.85B | ---- | -42.78%4.41B | ---- | -38.64%5.58B |
Advance payment | 92.12%147.45M | -94.71%72.62M | -30.69%77.73M | -7.75%83.05M | -28.69%76.75M | 27.72%1.37B | -5.30%112.15M | -23.61%90.03M | -52.99%107.63M | 637.02%1.08B |
Inventories | -22.60%14.7B | -5.19%15.91B | 18.31%19.12B | 18.12%18.75B | 19.97%19B | 3.74%16.78B | 73.61%16.16B | -4.25%15.87B | 0.27%15.83B | 4.99%16.17B |
Receivable financing | 38.20%27.25M | 59.06%72.66M | 297.33%27.04M | 36.34%13.47M | 435.91%19.72M | 50.43%45.68M | 112.38%6.8M | 171.10%9.88M | -24.72%3.68M | -60.63%30.37M |
Assets held for sale | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Non-current assets due within one year | --309.23K | 5.05%309.23K | --294.36K | --294.36K | ---- | -99.98%294.36K | ---- | ---- | ---- | -64.54%1.26B |
Other current assets | 48.73%1.31B | 57.22%1.23B | 97.30%1.49B | 16.35%1.34B | -31.97%878.15M | -21.01%784.29M | -57.90%755.05M | -44.74%1.15B | -31.33%1.29B | -30.96%992.88M |
Total current assets | -3.37%32.69B | -4.66%32.11B | 15.02%36.1B | 1.75%34.54B | 2.48%33.83B | -8.56%33.69B | -4.10%31.39B | -22.22%33.94B | -20.32%33.01B | -18.96%36.84B |
Non Current assets | ||||||||||
Debt investment | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other debt investment | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other equity investment | -14.02%8.78B | -7.35%8.96B | -7.79%8.11B | 31.69%10.49B | -10.97%10.21B | -16.41%9.67B | -20.63%8.8B | -29.77%7.97B | 8.58%11.47B | 24.29%11.56B |
Other non-current financial assets | -44.14%1.51B | 5.73%2.51B | 10.39%2.63B | 4.53%2.71B | 4.53%2.71B | -8.41%2.37B | 8.07%2.38B | 23.21%2.59B | 23.21%2.59B | 135.05%2.59B |
Investment real estate | -7.45%2.18B | 1.52%2.2B | 150.47%2.3B | 149.79%2.32B | 129.61%2.35B | 237.04%2.16B | -63.23%917.33M | 140.07%929.15M | 109.20%1.02B | 58.81%642.17M |
Long-term equity investment | 21.12%23.84B | 20.97%22.98B | 11.56%20.91B | 15.65%20.75B | 13.27%19.68B | 12.05%18.99B | 28.26%18.74B | 26.92%17.95B | 27.58%17.38B | 29.94%16.95B |
Long term receivable account | 5,818.77%353.91M | 5,898.88%341.05M | -71.57%5.69M | --5.69M | --5.98M | --5.69M | -98.62%20M | ---- | ---- | ---- |
Fixed assets | ---- | ---- | ---- | 0.30%9B | ---- | 6.25%8.58B | ---- | 46.76%8.97B | ---- | 27.88%8.07B |
Constru in process | ---- | ---- | ---- | -37.84%793.26M | ---- | -52.78%987.17M | ---- | -66.59%1.28B | ---- | 4.76%2.09B |
Productive biological assets | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Oil and gas assets | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Intangible assets | 1.95%334.73M | -7.03%309.76M | -20.86%319.58M | -20.76%324.31M | -23.23%328.33M | -22.99%333.19M | 10.38%403.82M | 10.40%409.3M | 13.87%427.71M | 20.64%432.68M |
Development expenditure | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Goodwill | -17.84%35.67M | -17.84%35.67M | 21.71%43.42M | 21.71%43.42M | 21.71%43.42M | 21.71%43.42M | 0.00%35.67M | 0.00%35.67M | 0.00%35.67M | 0.00%35.67M |
Long deferred expense | -9.21%18.9M | 34.45%28.09M | 48.57%25.89M | 43.19%27.55M | -43.46%20.81M | -19.31%20.89M | 2.24%17.42M | 11.16%19.24M | 99.49%36.81M | 834.89%25.89M |
Deferred tax assets | -45.33%263.22M | -26.71%260.99M | 28.56%486.33M | 37.64%439.23M | 45.69%481.46M | 2.07%356.1M | 75.97%378.3M | 25.94%319.11M | 26.63%330.48M | 39.03%348.88M |
Usufruct assets | 25.25%667.65M | 23.67%677.36M | 3.39%515.28M | 7.60%524.47M | 7.03%533.07M | -1.82%547.72M | -4.16%498.4M | -10.53%487.44M | -7.65%498.08M | -8.95%557.85M |
Other non current assets | -89.96%3.54M | -83.30%4.28M | -6.54%8.03M | -34.96%7.59M | -37.53%35.21M | -66.67%25.64M | -92.16%8.59M | -67.74%11.67M | -80.26%56.37M | -74.27%76.93M |
Adjustment items of non current assets | ---- | ---- | ---- | ---- | 0.00%-0.01 | ---- | ---- | ---- | ---0.01 | ---- |
Total non current assets | 5.04%48.4B | 9.76%48.4B | 5.96%45.13B | 15.81%47.44B | 5.08%46.08B | 1.63%44.09B | 3.33%42.59B | 0.86%40.96B | 11.96%43.85B | 23.62%43.38B |
Total assets | 1.48%81.09B | 3.52%80.51B | 9.80%81.23B | 9.44%81.97B | 3.96%79.91B | -3.05%77.78B | 0.04%73.98B | -11.09%74.9B | -4.64%76.86B | -0.41%80.22B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 1.13%13.47B | 4.53%13.56B | -11.94%12.3B | -2.64%13.4B | -6.14%13.32B | -15.19%12.97B | -12.21%13.97B | -33.02%13.77B | -26.93%14.2B | -19.41%15.3B |
Transactional financial liabilities | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Notes payable and accounts payable | -19.16%856.81M | 0.86%1.21B | -12.80%929.72M | -23.46%1.01B | -6.97%1.06B | 4.71%1.2B | 33.55%1.07B | 119.36%1.31B | 123.57%1.14B | 99.79%1.15B |
-Notes payable | -6.48%61.4M | 2.62%59.11M | -25.68%58.5M | -75.53%66.16M | -77.85%65.65M | -42.86%57.6M | -27.85%78.72M | 152.70%270.37M | 227.13%296.33M | 100.07%100.81M |
-Accounts payable | -19.99%795.41M | 0.78%1.16B | -11.78%871.22M | -9.97%939.69M | 17.94%994.18M | 9.28%1.15B | 43.26%987.52M | 112.10%1.04B | 101.18%842.95M | 99.76%1.05B |
Contract liabilities | 23.12%10.14B | 47.27%10.96B | 98.28%12.63B | 40.38%11.1B | 7.68%8.24B | -42.01%7.44B | -41.79%6.37B | -55.09%7.91B | -51.85%7.65B | -17.87%12.83B |
Advance receipts | 32.36%12.09M | 32.65%23.28M | -35.43%8.35M | -35.18%10.9M | -40.18%9.13M | -21.97%17.55M | -22.96%12.94M | -9.59%16.81M | -16.66%15.27M | 10.07%22.49M |
Salaries payable | 23.55%170.26M | 14.53%450.9M | 7.53%255.84M | -20.30%204.09M | -6.66%137.81M | 1.95%393.7M | -2.11%237.92M | 22.14%256.09M | 13.88%147.64M | 1.26%386.18M |
Taxs payable | -82.79%271.79M | -74.82%509.02M | -83.24%293.16M | -53.15%926.81M | -33.51%1.58B | 10.53%2.02B | -24.62%1.75B | 60.78%1.98B | 25.50%2.38B | -39.97%1.83B |
Other payable (including interest and dividends) | -23.99%2.21B | -22.19%2.35B | -11.63%2.8B | -19.19%2.65B | -23.72%2.91B | -29.91%3.02B | 6.49%3.17B | -23.02%3.28B | 1.34%3.82B | 21.10%4.31B |
-Interest payable | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Dividend payable | --0 | --0 | ---- | ---- | ---- | ---- | --8.89M | --30.8M | ---- | ---- |
-Other payable | ---- | -22.19%2.35B | ---- | -18.42%2.65B | ---- | -29.91%3.02B | ---- | -23.74%3.25B | ---- | 21.10%4.31B |
Hold and for sell liabilities | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Non current liabilities due within one year | -25.13%3.79B | 11.79%4.03B | 199.35%5.07B | 145.29%4.15B | 165.78%5.06B | 59.93%3.61B | 19.86%1.69B | 1.23%1.69B | 314.32%1.9B | -23.39%2.26B |
Other current liabilities | 22.52%925.21M | 45.70%995.96M | 102.64%1.19B | 38.97%1.01B | 5.99%755.18M | -41.47%683.58M | -41.03%588.88M | -55.03%726.6M | -55.38%712.53M | -17.40%1.17B |
Adjustment items of current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- |
Total current liabilities | -3.69%31.85B | 8.71%34.1B | 22.96%35.49B | 11.40%34.47B | 3.49%33.07B | -20.09%31.36B | -18.99%28.86B | -35.23%30.94B | -26.86%31.96B | -15.67%39.25B |
Current liabilities | ||||||||||
Long term loan | 31.69%7.98B | -16.81%6.22B | -8.69%6.89B | -3.70%7.02B | -13.37%6.06B | 29.70%7.47B | 52.20%7.54B | 27.45%7.29B | 25.39%7B | 32.07%5.76B |
Bonds payable | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Long term account payable | ---- | ---- | ---- | 198.60%13.08M | ---- | 462.04%24.62M | ---- | -51.78%4.38M | ---- | 0.00%4.38M |
Specific account payable | ---- | ---- | ---- | 147.51%2.92M | ---- | 111.23%2.7M | ---- | 1.36%1.18M | ---- | 40.00%1.28M |
Estimate liabilities | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Deferred tax liabilities | -43.82%369.06M | -27.11%379.04M | 8.73%546.74M | 12.94%628.94M | -4.75%656.88M | -35.28%520.05M | 2.00%502.85M | -0.90%556.86M | 20.41%689.61M | 36.21%803.6M |
Long term deferred income | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Lease liabilities | 14.41%360.47M | 15.58%338.31M | 5.71%321.76M | 9.54%311.87M | 8.67%315.06M | 27.27%292.7M | -40.08%304.38M | 3.05%284.72M | -0.49%289.94M | -33.33%229.97M |
Other non current liabilities | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total non current liabilities | 23.36%8.72B | -16.46%6.94B | -7.04%7.77B | -1.96%7.98B | -11.45%7.07B | 22.23%8.31B | 39.77%8.35B | 23.89%8.14B | 22.60%7.98B | 28.25%6.8B |
Adjustment items of total current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- |
Total liabilities | 1.07%40.57B | 3.44%41.04B | 16.23%43.25B | 8.62%42.45B | 0.50%40.14B | -13.84%39.68B | -10.54%37.21B | -28.08%39.08B | -20.44%39.94B | -11.18%46.05B |
Shareholders equity | ||||||||||
Paid-in capital | -0.00%4.63B | -0.00%4.63B | -0.00%4.63B | -0.00%4.63B | -0.00%4.63B | -0.00%4.63B | -0.00%4.63B | -0.00%4.63B | 0.00%4.63B | 0.00%4.63B |
Other equity instruments | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Equity of prefer stock | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Equity of Perpetual debt | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Capital reserve funds | 6.81%1.66B | 8.86%1.66B | 1.32%1.55B | 3.16%1.55B | 25.24%1.55B | 32.14%1.52B | 46.58%1.53B | 57.69%1.5B | 38.65%1.24B | 60.79%1.15B |
Surplus reserve funds | -0.00%2.83B | -0.00%2.83B | -0.00%2.83B | 0.01%2.83B | -0.00%2.83B | -0.00%2.83B | -0.01%2.83B | -0.01%2.83B | -0.00%2.83B | -0.00%2.83B |
Retained profit | 3.19%34.75B | 3.36%33.79B | 4.36%33.22B | 5.89%32.58B | 6.49%33.68B | 10.67%32.69B | 11.46%31.83B | 16.81%30.77B | 14.77%31.62B | 9.53%29.54B |
Less:Treasury stock | -87.42%36.32M | -87.42%36.32M | -87.42%36.32M | -87.34%36.57M | -52.25%288.8M | -52.25%288.8M | -79.01%288.75M | -78.44%288.75M | -56.88%604.78M | -42.00%604.78M |
Other composite income | -25.64%-3.61B | -5.44%-3.66B | -13.82%-4.48B | 39.73%-2.28B | 10.23%-2.87B | 2.29%-3.47B | -11.06%-3.93B | -2.21%-3.79B | 25.22%-3.2B | 36.24%-3.55B |
Ordinary risk reserve funds | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Shareholders equity without minority interests | 1.76%40.22B | 3.42%39.22B | 3.06%37.72B | 10.14%39.27B | 8.24%39.53B | 11.53%37.92B | 13.86%36.6B | 20.02%35.66B | 20.82%36.52B | 19.14%34B |
Minority interests | 23.91%295.65M | 41.56%254.5M | 59.32%257.29M | 51.17%253.3M | -40.60%238.6M | 4.79%179.78M | -18.38%161.49M | -15.83%167.56M | 140.53%401.66M | 1.76%171.56M |
Other items effecting shareholder equity | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- |
Total shareholder equity | 1.89%40.52B | 3.60%39.47B | 3.30%37.98B | 10.33%39.53B | 7.71%39.77B | 11.50%38.1B | 13.66%36.76B | 19.78%35.82B | 21.47%36.92B | 19.04%34.17B |
Adjustment items of liabilities and equity | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- |
Total liabilityies and equity | 1.48%81.09B | 3.52%80.51B | 9.80%81.23B | 9.44%81.97B | 3.96%79.91B | -3.05%77.78B | 0.04%73.98B | -11.09%74.9B | -4.64%76.86B | -0.41%80.22B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data